
| generic name | brand name | drug class or drug category | general use |
| amphetamine/dextroamphetamine | Adderall | central nervous system stimulant | ADHD |
| dextroamphetamine | Dexedrine | central nervous system stimulant | attention-deficit hyperactivity disorder (ADHD) |
| fentanyl | Duragesic | narcotic analgesic | chronic pain |
| fentanyl citrate | Actiq; Fentora; Onsolis | narcotic (opioid) analgesic | to manage breakthrough pain in cancer patients |
| hydrocodone/acetaminophen | Lortab; Norco; Vicodin; Hycet | narcotic analgesic | to relieve moderate to severe pain |
| hydrocodone/chlorpheniramine | Tussicaps | narcotic cough suppressant and antihistamine | to treat symptoms due to cough, colds, allergies, or flu |
| hydrocodone/chlorpheniramine | Tussionex | narcotic antitussive and antihistamine | to treat symptoms due to cough, colds, allergies, or flu |
| hydrocodone, chlorpheniramine, pseudoephedrine | Zutripro | antitussive, antihistamine and nasal decongestant | for the relief of cough, nasal congestion, and upper respiratory allergies |
| hydrocodone/ibuprofen | Vicoprofen | narcotic (opioid) analgesic | short-term pain relief |
| hydrocodone/homatropine | Hycodan; Hydromet | anticholinergic and narcotic cough suppressant | indicated for the symptomatic relief of cough |
| hydromorphone | Dilaudid; Exalgo | narcotic analgesic; opioid agonist | to treat moderate to severe pain |
| lisdexamfetamine | Vyvanse | central nervous system stimulant | attention deficit hyperactivity disorder (ADHD) |
| meperidine | Demerol | narcotic analgesic | to treat moderate to severe pain |
| methadone | Dolophine; Methadose | narcotic analgesic; narcotic suppressant | to treat severe pain; to treat narcotic addiction |
| methylphenidate (oral) | Concerta; Ritalin; Methylin | central nervous system stimulant | ADHD |
| methylphenidate (patch) | Daytrana | central nervous system stimulant | ADHD |
| morphine sulfate | MS Contin; Kadian; Avinza; Oramorph | narcotic analgesic | moderate to severe pain |
| oxycodone | OxyContin; Roxicodone | narcotic analgesic | moderate to severe pain |
| oxycodone/acetaminophen | Percocet | narcotic analgesic | moderate to severe pain |
| oxymorphone | Opana | narcotic pain reliever | to treat moderate-to-severe pain |
| tapentadol | Nucynta | opioid analgesic | moderate to severe acute pain |
| Schedule II same as C-II --- substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. --- there are no refills for a C-II prescription. --- federal law requires the patient's street address on Rx's for controlled substances. --- prescriptions for Schedule II controlled substances must be written and be signed by the practitioner. --- a C-II prescription must have the control number, physician's DEA number, and physician's DPS number. --- in some states, a C-II prescription must be filled within 7 days of issue and in other states it must be filled within 72 hours. In Texas, a C-II prescription must be filled within 21 days of issue. --- labels for C-II controlled substances must contain the fill date. --- for C-II drugs, the auxiliary label "Transfer Warning" is required. --- labels for C-II drugs should contain the statement, "Caution: Federal law prohibits the transfer of this drug to any person other than the person for whom it was prescribed." --- after a pharmacist fills a C-II prescription, the pharmacist must sign and date the original prescription and this prescription must be filed separately from other prescriptions. --- schedule II controlled substance prescriptions, written for a patient enrolled in hospice, may be faxed to a pharmacy for dispensing. --- physician assistants (PA) and advanced practice nurses (APN) are not allowed to issue prescriptions for C-II drugs. --- in emergency situations, a prescription for a Schedule II controlled substance may be telephoned to the pharmacy and the prescriber must follow up with a written prescription being sent to the pharmacy within 72 hours. --- a DEA triplicate form 222 must be used when ordering C-II drugs. Purchase of C-II drugs must be authorized by a pharmacist on the DEA form. --- a physical inventory of C-II drugs is required every two years. |